thirty-three patients were randomized prior to pelvic radiotherapy to receive the bile acid-sequestering resin colestipol hydrochloride , 5 grams qid , during the entire time of their therapy or diphenoxylate hydrochloride and atropine sulfate 2.5-20 mg per day ( control ) if they experienced diarrhea .
C0282145
diphenoxylate hydrochloride
C0011991
diarrhea